By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Starr FMStarr FMStarr FM
  • Home
  • Election Hub
  • General
    GeneralShow More
    ‘Perhaps we need a Ghana Cocaine Board’ – Mpraeso MP mocks drug trafficking situation
    November 21, 2026
    Samuel Okudzeto Ablakwa elected chair of Nordic-African foreign ministers for 2027
    November 20, 2026
    Sniffer dogs are good but human compromise remains the biggest threat at Ghana’s airports – Adib Sani
    November 20, 2026
    Unqualified nursing students must not be allowed to graduate – Deputy Health Minister
    November 20, 2026
    Energy Commission backs 600 MW state solar plant to power Ghana’s renewable transition
    November 20, 2026
  • Business
    BusinessShow More
    Jospong’s AAC partners Turkish ChitoGlobal to test shell-based crop treatments in Ghana
    November 21, 2026
    Big Push: Mpraeso MP questions inconsistent figures in 2027 Budget
    November 21, 2026
    “Where Is the GH¢100 million for One Million Coders?” – Mpraeso MP demands accountability
    November 21, 2026
    Mpraeso MP urges government to give Ghana’s mines to competent local businesses
    November 21, 2026
    ‘Demand the Invoices’ – GRA tells shoppers after discovering tax breaches at the Achimota Mall
    November 20, 2026
  • Politics
    PoliticsShow More
    Parliament considers reverting to 10 a.m. sittings to tackle persistent low attendance
    November 20, 2026
    2027 Budget: “There’s a true reflection of hardship” – Minority storms Techiman Market
    November 20, 2026
    Let’s focus on the bigger picture and win the 2028 election — Kombat to NDC
    November 20, 2026
    Government targets completion of 1,506 Saglemi Housing Units by December 2027 – Ahmed Ibrahim
    November 20, 2026
    Galamsey fight is a herculean task, but progress offers hope – Zambaga
    November 20, 2026
  • Entertainment
    EntertainmentShow More
    Ghana’s $1B Creative Bet Needs Digital Rails – Lali & Lola
    November 20, 2026
    Prophet Joseph Atarah releases new single ‘Formula’
    November 18, 2026
    Chef Abbys returns to Ghana after creator engagements in Texas
    November 18, 2026
    Gov’t must invest in Ghana’s film industry to compete with foreign films – Bawumia
    November 18, 2026
    Bawumia calls for Broadcasting Act, tax incentives to boost Ghana’s film industry
    November 18, 2026
  • Sports
    SportsShow More
    Sports Minister accounts for US$4.67 Million spent on Black Stars’ 2026 World Cup campaign
    November 20, 2026
    We never gave GHC100 as birthday gift to Mohammed Polo – Hearts of Oak
    November 19, 2026
    Asante Kotoko appoints Stanley Menzo as Head Coach
    November 19, 2026
    Elite Academy–Prempeh extend Group A lead as Sogakope Cule top Group B
    November 14, 2026
    Black Stars bounce back with 2-0 victory over Somalia to revive AFCON 2027 hopes
    November 13, 2026
  • Technology
    TechnologyShow More
    Vatar (Makers of Lagos Life) Launches in Ghana
    November 15, 2026
    Samuel Nartey George elected Chair of AU Communications and ICT Committee
    October 29, 2026
    AVAS 2026: Accra to Drive Africa’s Tokenisation Agenda
    October 28, 2026
    Yellow Card wins Gold in Diamond category at 2026 Money Awards
    October 27, 2026
    Dorcas Affo-Toffey engages Ceris Technologies on port digitalisation, cybersecurity
    October 22, 2026
  • International
    InternationalShow More
    Jospong’s AAC partners Turkish ChitoGlobal to test shell-based crop treatments in Ghana
    November 21, 2026
    Samuel Okudzeto Ablakwa elected chair of Nordic-African foreign ministers for 2027
    November 20, 2026
    Kumasi Mayor seeks stronger France partnership to attract investment
    November 20, 2026
    Ghana’s Alex Apau Dadey named Entrepreneur of the Year at AABLA
    November 20, 2026
    Ablakwa: Ghana, Norway rolling out interventions to support startups and MSMEs
    November 20, 2026
  • Factometer
Search
© 2024 EIB Network Ltd. All Rights Reserved.
Reading: Africa’s long wait for the Covid-19 vaccine
Share
Notification Show More
Font ResizerAa
Starr FMStarr FM
Font ResizerAa
  • Headlines
  • Election Hub
  • General
  • Politics
  • Sports
  • Business
  • Entertainment
  • Factometer
Search
  • Headlines
  • Election Hub
  • General
  • Politics
  • Sports
  • Business
  • Entertainment
  • Factometer
Have an existing account? Sign In
Follow US
© 2024 EIB Network Ltd. All Rights Reserved.
Editors PickInternational

Africa’s long wait for the Covid-19 vaccine

Starrfm.com.gh
By
Starrfm.com.gh
Published: January 22, 2021
Share
SHARE

Africa will have to wait “weeks if not months” before receiving Covid-19 vaccines approved by the World Health Organization, according to various officials working towards getting doses for the continent.

Close to 900 million doses have been secured so far through various initiatives, enough to inoculate about 30% of the continent’s 1.3 billion people this year.

Hoarding by wealthy nations, funding shortfalls, regulations and cold chain requirements have slowed the process of rolling out the vaccines. “The world is on the brink of a catastrophic moral failure and the price will be paid with lives and livelihoods in the poorest countries,” warned WHO head Dr Tedros Ghebreyesus.

Calls for equity have been growing. Close to 40 million doses have been administered in at least 49 higher-income countries, compared to just 25 doses given in just one of the lowest-income countries, according to Dr Tedros. “Not 25 million, not 25,000, just 25,” he said, without saying which country.

So far, none of the main vaccines has yet been administered in Africa, two months after the first doses were rolled out in Europe.

A coalition of organisations and activists dubbed The People’s Vaccine Alliance found that “rich nations representing just 14% of the world’s population had bought up more than half (53%) of all the most promising vaccines.” That included all of Moderna’s vaccines for 2021 and 96% of Pfizer’s expected production.

Canada topped the chart, according to the data by analytics company Airfinity, “with enough doses to vaccinate each Canadian five times”. Much of that demand has to be met before lower income countries can have a turn.

‘Don’t look for super profits’

In Africa, the situation rekindles memories of the 1990s, when antiretroviral (ARVs) treatment for HIV/Aids was made in the United States. Even though the continent had a much bigger population of people infected with HIV, it took at least six years before the life-saving treatment could be available for Africans.

Twelve million people died in Africa from Aids-related complications in a decade, even as mortality in the US dropped drastically, according to analyses by the Africa Centers for Disease Control and Prevention.

UNAids Executive Director Winnie Byanyima has been at the forefront of those calling for fairness from Covid-19 vaccine manufacturers.

“We’re not asking them to make loses,” she told the BBC. With the ARVs, it was pressure from people living with HIV and champions of the right to life that got governments to allow for the production of generic treatments which were much more affordable. “The price [of antiretroviral treatment per person] dropped from $10,000 per year [per person] to just $100 per year.”

She wants the same approach for the Covid-19 vaccine,urging the pharmaceutical industry “not to be driven by the desire for super profits”. They can still make profits even if they share their formulae, she added.

‘Queue-jumping’

The WHO head is also calling for equity: “Even as they speak the language of equitable access, some countries and companies continue to prioritise bilateral deals, going around Covax, driving up prices and attempting to jump to the front of the queue,” he said.

The Covax facility is an initiative of the WHO and the Vaccine Alliance to equitably distribute Covid-19 vaccines across the world.

“Most supply of the leading vaccines was pre-ordered by wealthy nations even before the safety and efficacy data was made available,” said Dr Richard Mihigo, head of immunisation and vaccine development at the WHO Africa office.

Asked why Covax didn’t do the same, he said securing funding was the first task the initiative engaged in. So far, $6bn has been raised out of a target of $8bn for 92 middle- and low-income countries, according to Thabani Maphosa of the Vaccine Alliance, Gavi.

So far, the facility has secured two billion doses for this group of countries, which includes all of Africa. Some 600 million are for the continent.

The African Union has made arrangements for member states to apply for $7bn funding from lenders, which would cover up to 270 million vaccines, according to its current chairperson, President Cyril Ramaphosa of South Africa.

‘Mammoth operation’

But it is not just the purchase of vaccines that needs funding. Countries have also been ramping up their cold chains as they prepare for their arrival. These are especially important for the Pfizer vaccine, which must be kept at -70C.

The UN children’s agency, Unicef, which usually deals with distribution of childhood vaccines, will be handling the logistics of delivering Covid-19 vaccines under the Covax facility. The agency is preparing to transport at least twice its usual capacity – what it calls “a mammoth and historic logistical operation”.

2px presentational grey line

More about coronavirus in Africa:

  • Rising Africa Covid infections causing concern
  • Why has South Africa not started vaccinating?
  • Live tracker: Coronavirus cases in Africa
2px presentational grey line

But before it can be done, countries need to have ready infrastructure to receive and administer the doses. Benjamin Schreiber, who is coordinating the Covax facility for Unicef, says he is “worried that we haven’t resourced the roll-out and the preparation enough”.

“What we’re seeing in the roll-out in some of the high-income countries is that it’s complicated, it needs to be resourced and properly planned, and there haven’t been enough global resources to lower-income countries,” he told the BBC.

In spite of the shortfalls, he paints a more optimistic picture of the continent’s ability to introduce new vaccines. “Africa has a lot more experience than many other regions – we’ve done so many vaccine introductions over the last 10 years and there’s good expertise to organise targeted vaccination campaigns.”

He adds that some countries that have dealt with Ebola also have expertise and ultra-cold chain experience and infrastructure. Even before the pandemic hit, the organisation says it has been supporting cold-chain infrastructure in low-income countries, including the installation of 70,000 fridges, half of which are solar-powered.

The country-by-country status was not immediately available. Mr Maphosa from Gavi said countries were currently submitting documents to the facility to inform it of their readiness to roll out vaccines.

Only one vaccine approved by WHO

But even if they were ready, regulatory issues still stand in the way. Under the Covax facility, only WHO-approved vaccines can be bought. So far, only Pfizer’s has been listed for emergency use by the WHO. The process to approve Moderna and Astrazeneza vaccines is ongoing.

“Vaccines that are being recommended for emergency use need absolutely to meet minimum standards for safety and efficacy,” said Dr Mihigo.

More developed countries such as the US and EU states have regulatory agencies that “complement” WHO’s work and could therefore roll out vaccines without the body’s approval. However, in the developing world, many countries rely on the WHO to do the due diligence, adds Dr Mihigo.

That assurance of quality has a direct impact on people’s willingness to take vaccines. A study conducted by the Africa CDC and the London School of Hygiene and Tropical Medicine in the last quarter of 2020 found that a majority of Africans – four out of every five – would be willing to take a Covid-19 vaccine “if it was deemed safe and effective”.

Several countries have however rolled out vaccines that have yet to be approved by the WHO. “Our advice is for countries to rely not just on the body’s pre-qualification, but also any other competent ‘Stringent Regulatory Authority’,” said Dr Mihigo.

The Seychelles, Morocco and Egypt are administering the Chinese-made Sinopharm vaccine and Guinea, the Russian Sputnik V.

Africa CDC’s director John Nkengasong said there were no negotiations going on to purchase these two vaccines, but that the regional body was “in talks” with the producing countries. More and more African countries are showing interest in these two vaccine candidates as the wait for the leading ones from the West continues.

Aids lessons ‘not learnt’

The BBC could not establish a specific date from the official involved of when the Covax vaccines could be delivered to the continent. The most optimistic estimate was February but stretching to the end of March for the initial consignments of the Covax facility.

“We want to get the first doses out as fast as possible,” said Unicef’s Mr Schreiber.

The 270 million doses secured directly by the African Union are expected to be delivered from April.

No doses from WHO-approved vaccines are currently available for distribution on the continent.

“That lesson [from the HIV antiretroviral treatment] has still not been learnt,” said Ms Byanyima from UNAids.

Source: BBC

Janet Jackson, 50, gives birth to a boy
Christchurch mosque shootings: Forty dead after New Zealand attacks
Burkina Faso coup: Ecowas condemns military takeover
Online businesses to be taxed from April 1
Will Smith banned from Oscars for 10 years over slap
Share This Article
Facebook Email Print
Share
Previous Article Google threatens to withdraw search engine from Australia
Next Article Leningrad nuclear power plant tests diagnostics robot for reactor-enabled unit

Starr 103.5FM

Starr FMStarr FM
Follow US
© 2024 EIB Network Ltd. All Rights Reserved.
newsletter icon
Join Us!
Subscribe to our newsletter and never miss our latest in news, podcasts etc..

Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?